US Manufactured Target buyers and procurement teams at research institutions and medical facilities that prioritize domestically manufactured sterilization solutions. Emphasize US-based production as a differentiator for quality control, supply security, and regulatory alignment.

Autoclave Upgrades Position the X1 controller and SterilCARE maintenance program as a packaged upgrade path and total cost of ownership reduction for existing autoclave fleets. Highlight potential for service contracts, extended warranties, and preventive maintenance revenue.

Strategic Partnerships Leverage recent partnerships and investor interest to open opportunities with diabetes research labs, clinical trial sites, and university-affiliated programs. Use collaboration history to approach adjacent segments and co-brand demonstrations.

Midmarket Scale Align outreach to small-to-mid market labs and clinics within the 11-50 employee range and revenue banded at mid-market. Emphasize cost-effective steam sterilization solutions, rapid deployment, and responsive local support.

Growth Signals Capitalize on funding activity and expansion momentum noted by Gemini Investors and ongoing product enhancements. Offer flexible financing, pilot programs, and case studies to reduce risk for procurement teams evaluating new sterilization platforms.